NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
NNVC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.56%423.330.0%$6024.94m
BNTXBioNTech SE -5.62%339.010.0%$1181.48m
NVAXNovavax, Inc. -4.47%226.9279.4%$901.81m
SNSSSunesis Pharmaceuticals, Inc. -3.67%8.390.7%$586.49m
AMGNAmgen, Inc. -1.95%215.111.4%$548.49m
REGNRegeneron Pharmaceuticals, Inc. -1.69%640.892.7%$486.09m
GILDGilead Sciences, Inc. -0.91%70.961.0%$430.39m
ILMNIllumina, Inc. -2.02%438.003.5%$397.21m
TECHBio-Techne Corp. -1.04%528.824.5%$352.26m
BIIBBiogen, Inc. -0.57%298.491.7%$304.57m
VRTXVertex Pharmaceuticals, Inc. -1.40%185.671.9%$238.22m
ISEEIVERIC bio, Inc. -2.41%16.220.0%$190.09m
BGNEBeiGene Ltd. -1.15%398.501.3%$184.03m
LIFEaTyr Pharma, Inc. -0.87%10.223.2%$142.93m
EXASEXACT Sciences Corp. -2.77%105.1518.1%$131.92m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.